A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers

Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression

NCT01716104 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

NCT03887858 ·Status: COMPLETED ·Phase: PHASE1

A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia

NCT07146386 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

NCT02431754 ·Status: COMPLETED ·Phase: PHASE4

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

NCT05236634 ·Status: UNKNOWN ·Phase: NA

A Study in Men With Benign Prostatic Hyperplasia

NCT01097707 ·Status: TERMINATED ·Phase: PHASE2

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy

NCT02961114 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

NCT00540124 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NCT00237536 ·Status: TERMINATED ·Phase: PHASE2

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

NCT01922375 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NCT00435448 ·Status: TERMINATED ·Phase: PHASE3

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

NCT00969072 ·Status: COMPLETED ·Phase: PHASE2

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

NCT01301599 ·Status: COMPLETED ·Phase: PHASE4

Botulinum Toxin Injection for the Management of BPH

NCT00451191 ·Status: COMPLETED ·Phase: PHASE2

One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients

NCT00472251 ·Status: COMPLETED

A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

NCT00044226 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia

NCT07270432 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Evaluation of the Water Vapor Thermal Therapy System for the Treatment of Benign Prostatic Hyperplasia

NCT06725212 ·Status: RECRUITING ·Phase: NA

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

NCT00077012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

NCT00962390 ·Status: COMPLETED ·Phase: PHASE2

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

NCT00224107 ·Status: COMPLETED ·Phase: PHASE3

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

NCT02417831 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

NCT02390882 ·Status: COMPLETED ·Phase: PHASE3

HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH

NCT02332538 ·Status: COMPLETED ·Phase: NA

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH

NCT02972268 ·Status: COMPLETED ·Phase: PHASE3